Correction - It is slide 29 that is missing and not slide 27 as I said in my previous post. There is a dramatic difference in market penetration between this analysis and the companies assumption along with a potential for increased pricing based on NNT and ICER score. If we ever get a positive Futility Assessment the rerating could be outstanding.

Let's get the darn financing taken care of and rocket forward.

Not to long to wait now. 

tada